Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: A case-control analysis

Gynecologic Oncology

Volumn 114, Issue 2, 2009, Pages 327-331

  Zhou, Xiaoyi ^a   Han, Suping ^a   Wang, Sumin ^a   Chen, Xiaojun ^a,b   Dong, Jing ^a   Shi, Xiaoyan ^a   Xia, Yankai ^a   Wang, Xinru ^a   Hu, Zhibin ^a   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Tumor Hospital of Nantong City   (China)

Author keywords

BARD1; BRCA1; Cervical cancer; Polymorphism; TP53

Indexed keywords

AMINO ACID; BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; PROTEIN P53; VIRUS PROTEIN;

ADULT; ARTICLE; CANCER RISK; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER;

BRCA1 PROTEIN; CASE-CONTROL STUDIES; CHINA; FEMALE; GENES, BRCA1; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UTERINE CERVICAL NEOPLASMS;

EID: 67549118425     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.05.011     Document Type: Article

References (30)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 2 (2005) 74-108
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2 5 (2002) 342-350
3. International Agency for Research of Cancer Human Papillomavirus. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Vol. 64 (1995), Lyon
4. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 1 (1999) 12-19
5. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., and Unger E.R. Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 56 RR-2 (2007) 1-24
6. Roden R., and Wu T.C. How will HPV vaccines affect cervical cancer?. Nat. Rev. Cancer 6 10 (2006) 753-763 Review
7. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. (Lond). 110 5 (2006) 525-541
8. Münger K., Baldwin A., Edwards K.M., Hayakawa H., Nguyen C.L., Owens M., et al. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 78 21 (2004) 11451-11460
9. Dyson N., Howley P.M., Münger K., and Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243 4893 (1989) 934-937
10. Hengstermann A., D′silva M.A., Kuballa P., Butz K., Hoppe-Seyler F., and Scheffner M. Growth suppression induced by downregulation of E6-AP expression in human papillomavirus-positive cancer cell lines depends on p53. J. Virol. 79 14 (2005) 9296-9300
11. Zhang Y., Fan S., Meng Q., Ma Y., Katiyar P., Schlegel R., et al. BRCA1 interaction with human papillomavirus oncoproteins. J. Biol. Chem. 280 39 (2005 Sep 30) 33165-33177
12. Ouchi T., Monteiro A.N., August A., Aaronson S.A., and Hanafusa H. BRCA1 regulates p53-dependent gene expression. Proc. Natl. Acad. Sci. U. S. A. 95 5 (1998) 2302-2306
13. Zhang H., Somasundaram K., Peng Y., Tian H., Zhang H., Bi D., et al. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16 13 (1998) 1713-1721
14. Chai Y.L., Cui J., Shao N., Shyam E., Reddy P., and Rao V.N. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter. Oncogene 18 1 (1999) 263-268
15. Yim E.K., Lee K.H., Myeong J., Tong S.Y., Um S.J., and Park J.S. Novel interaction between HPV E6 and BARD1 (BRCA1-associated ring domain 1) and its biologic roles. DNA Cell Biol. 26 10 (2007) 753-761
16. Oliveira S., Sousa H., Santos A.M., Pinto D., Pinto-Correia A.L., Fontoura D., et al. The p53 R72P polymorphism does not influence cervical cancer development in a Portuguese population: a study in exfoliated cervical cells. J. Med. Virol. 80 3 (2008) 424-429
17. Ciotti M., Coletti A., Giuliani L., Cappiello G., Syrjanen K., and Favalli C. The p53 codon 72 arg/arg homozygous women in central Italy are at increased risk for HPV infections. Anticancer Res. 26 5B (2006) 3745-3748
18. Chen X., Han S., Wang S., Zhou X., Zhang M., Dong J., et al. Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women. Clin. Cancer Res. 15 1 (2009) 400-405
19. Huo X., Hu Z., Zhai X., Wang Y., Wang S., Wang X., et al. Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis. Breast Cancer Res. Treat. 102 3 (2007 May) 329-337
20. Ke X., Collins A., and Ye S. PIRA PCR designer for restriction analysis of single nucleotide polymorphisms. Bioinformatics 17 9 (2001) 838-839
21. Thompson D., and Easton D.F. Breast Cancer Linkage Consortium. Cancer incidence in BRCA1 mutation carriers. J. Natl. Cancer Inst. 94 18 (2002) 1358-1365
22. Narayan G., Arias-Pulido H., Nandula S.V., Basso K., Sugirtharaj D.D., Vargas H., et al. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res. 64 9 (2004 May) 2994-2997
23. Miyai K., Furugen Y., Matsumoto T., Iwabuchi K., Hirose S., Kinoshita K., et al. Loss of heterozygosity analysis in uterine cervical adenocarcinoma. Gynecol. Oncol. 94 1 (2004) 115-120
24. Durocher F., Shattuck-Eidens D., McClure M., Labrie F., Skolnick M.H., Goldgar D.E., et al. Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum. Mol. Genet. 5 6 (1996) 835-842
25. Dunning A.M., Chiano M., Smith N.R., Dearden J., Gore M., Oakes S., et al. Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum. Mol. Genet. 6 2 (1997) 285-289
26. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393 6682 (1998 May) 229-234
27. Sousa H., Santos A.M., Pinto D., and Medeiros R. Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int. J. Mol. Med. 20 5 (2007) 731-741
28. Bondy M.L., Strom S.S., Colopy M.W., Brown B.W., and Strong L.C. Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J. Clin. Epidemiol. 47 1 (1994 Jan) 89-96
29. Theis B., Boyd N., Lockwood G., and Tritchler D. Accuracy of family cancer history in breast cancer patients. Eur. J. Cancer Prev. 3 4 (1994 Jul) 321-327
30. Mitchell R.J., Brewster D., Campbell H., Porteous M.E., Wyllie A.H., Bird C.C., et al. Accuracy of reporting of family history of colorectal cancer. Gut 53 2 (2004 Feb) 291-295